BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33781961)

  • 61. Feedback suppression of meal-induced glucagon-like peptide-1 (GLP-1) secretion mediated through elevations in intact GLP-1 caused by dipeptidyl peptidase-4 inhibition: a randomized, prospective comparison of sitagliptin and vildagliptin treatment.
    Baranov O; Kahle M; Deacon CF; Holst JJ; Nauck MA
    Diabetes Obes Metab; 2016 Nov; 18(11):1100-1109. PubMed ID: 27300579
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DPP IV inhibitor suppresses STZ-induced islets injury dependent on activation of the IGFR/Akt/mTOR signaling pathways by GLP-1 in monkeys.
    Zhang Y; Chen Y; Cheng J; Guo Z; Lu Y; Tian B
    Biochem Biophys Res Commun; 2015 Jan; 456(1):139-44. PubMed ID: 25446112
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.
    Kim SJ; Nian C; Doudet DJ; McIntosh CH
    Diabetes; 2008 May; 57(5):1331-9. PubMed ID: 18299314
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury.
    Terawaki Y; Nomiyama T; Kawanami T; Hamaguchi Y; Takahashi H; Tanaka T; Murase K; Nagaishi R; Tanabe M; Yanase T
    Cardiovasc Diabetol; 2014 Nov; 13():154. PubMed ID: 25407968
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dipeptidyl Peptidase-4 Inhibitor Decreases Allograft Vasculopathy Via Regulating the Functions of Endothelial Progenitor Cells in Normoglycemic Rats.
    Lin FY; Shih CM; Huang CY; Tsai YT; Loh SH; Li CY; Lin CY; Lin YW; Tsai CS
    Cardiovasc Drugs Ther; 2021 Dec; 35(6):1111-1127. PubMed ID: 32623597
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Dipeptidyl Peptidase-4 Inhibitor but not Incretins Suppresses Abdominal Aortic Aneurysms in Angiotensin II-Infused Apolipoprotein E-Null Mice.
    Kohashi K; Hiromura M; Mori Y; Terasaki M; Watanabe T; Kushima H; Shinmura K; Tomoyasu M; Nagashima M; Hirano T
    J Atheroscler Thromb; 2016; 23(4):441-54. PubMed ID: 26549734
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney.
    Joo KW; Kim S; Ahn SY; Chin HJ; Chae DW; Lee J; Han JS; Na KY
    BMC Nephrol; 2013 Apr; 14():98. PubMed ID: 23621921
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacological profiles of gemigliptin (LC15-0444), a novel dipeptidyl peptidase-4 inhibitor, in vitro and in vivo.
    Kim SH; Jung E; Yoon MK; Kwon OH; Hwang DM; Kim DW; Kim J; Lee SM; Yim HJ
    Eur J Pharmacol; 2016 Oct; 788():54-64. PubMed ID: 27298192
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dipeptidyl peptidase-IV inhibition prevents blood-retinal barrier breakdown, inflammation and neuronal cell death in the retina of type 1 diabetic rats.
    Gonçalves A; Marques C; Leal E; Ribeiro CF; Reis F; Ambrósio AF; Fernandes R
    Biochim Biophys Acta; 2014 Sep; 1842(9):1454-63. PubMed ID: 24769045
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice.
    Sauvé M; Ban K; Momen MA; Zhou YQ; Henkelman RM; Husain M; Drucker DJ
    Diabetes; 2010 Apr; 59(4):1063-73. PubMed ID: 20097729
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of PKF275-055, a dipeptidyl peptidase-4 inhibitor, on the development of atherosclerotic lesions in apolipoprotein E-null mice.
    Terasaki M; Nagashima M; Watanabe T; Nohtomi K; Mori Y; Miyazaki A; Hirano T
    Metabolism; 2012 Jul; 61(7):974-7. PubMed ID: 22225957
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The effects of DPP-IV inhibition in NOD mice with overt diabetes.
    Vargová L; Zacharovová K; Dovolilová E; Vojtová L; Cimburek Z; Saudek F
    Folia Biol (Praha); 2013; 59(3):116-22. PubMed ID: 23890479
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The dipeptidyl peptidase-4 inhibitor sitagliptin protects against dyslipidemia-related kidney injury in Apolipoprotein E knockout mice.
    Li J; Guan M; Li C; Lyv F; Zeng Y; Zheng Z; Wang C; Xue Y
    Int J Mol Sci; 2014 Jun; 15(7):11416-34. PubMed ID: 24972137
    [TBL] [Abstract][Full Text] [Related]  

  • 74. GLP-1 Receptor Blockade Reduces Stimulated Insulin Secretion in Fasted Subjects With Low Circulating GLP-1.
    Gray SM; Hoselton AL; Krishna R; Slentz CA; D'Alessio DA
    J Clin Endocrinol Metab; 2022 Aug; 107(9):2500-2510. PubMed ID: 35775723
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Uncoupling protein-2 mediates DPP-4 inhibitor-induced restoration of endothelial function in hypertension through reducing oxidative stress.
    Liu L; Liu J; Tian XY; Wong WT; Lau CW; Xu A; Xu G; Ng CF; Yao X; Gao Y; Huang Y
    Antioxid Redox Signal; 2014 Oct; 21(11):1571-81. PubMed ID: 24328731
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Dipeptidyl-peptidase-4 inhibitor, alogliptin, attenuates arterial inflammation and neointimal formation after injury in low-density lipoprotein (LDL) receptor-deficient mice.
    Akita K; Isoda K; Shimada K; Daida H
    J Am Heart Assoc; 2015 Mar; 4(3):e001469. PubMed ID: 25770025
    [TBL] [Abstract][Full Text] [Related]  

  • 77. DPP-4 Inhibition Leads to Decreased Pancreatic Inflammatory Profile and Increased Frequency of Regulatory T Cells in Experimental Type 1 Diabetes.
    Davanso MR; Caliari-Oliveira C; Couri CEB; Covas DT; de Oliveira Leal AM; Voltarelli JC; Malmegrim KCR; Yaochite JNU
    Inflammation; 2019 Apr; 42(2):449-462. PubMed ID: 30707388
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The dipeptidyl peptidase-4 inhibitor sitagliptin ameliorates renal injury in type 1 diabetic mice
    Li L; Lian X; Wang Z; Zheng J; Liu J; Chu Y; Teng Y; Zhang Z
    Pharmazie; 2019 Apr; 74(4):239-242. PubMed ID: 30940309
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dipeptidyl peptidase‑4 inhibitor sitagliptin prevents high glucose‑induced apoptosis via activation of AMP‑activated protein kinase in endothelial cells.
    Wu C; Hu S; Wang N; Tian J
    Mol Med Rep; 2017 Jun; 15(6):4346-4351. PubMed ID: 28440488
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of dipeptidyl peptidase 4 inhibition on arterial blood pressure is context dependent.
    Jackson EK; Mi Z; Tofovic SP; Gillespie DG
    Hypertension; 2015 Jan; 65(1):238-49. PubMed ID: 25368027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.